Field Trip Health Ltd
TSX:FTRP
Intrinsic Value
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of FTRP.
Field Trip Health Ltd's market capitalization is 61.3m CAD.
FTRP stock price is 2.9 CAD.
FTRP.
FTRP. Open DCF Valuation
FTRP. Open Relative Valuation
FTRP has upside potential of 322% compared to the average analyst price target.
Open Wall St Estimates
FTRP's Revenue has grown by an exceptional 406% over the past 12 months.
FTRP's ROE (Return on Equity) has significantly decreased in the last 3 years from -41% to -61%, and is approaching profitability.
FTRP's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -189% to -249%, and is approaching profitability.
FTRP has negative Operating Income for the last twelve months.
FTRP has negative Net Income for the last twelve months.
FTRP's ROE (Return on Equity) for the past 12 months is negative and is equal to -61%.
FTRP's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -249%.
FTRP has negative Net Debt. This means that the company has more cash and short-term investments (64m CAD) than debt (27m CAD).
FTRP has negative Gross Profit for the last twelve months.
FTRP's D/E (Debt to Equity) is very low and is equal to 0.4.
FTRP's long-term assets (102m CAD) exceed its long-term liabilties (35m CAD).
FTRP has negative Free Cash Flow for the last twelve months.
FTRP has negative three-year average ROE (Return on Equity): -68%. The company is not efficient at transforming stockholders' equity into net income.
FTRP has negative three-year average ROIC (Return on Invested Capital): -143%. The company is not efficient at using invested capital to generate operating income.
FTRP's short-term assets (69m CAD) exceed its short-term liabilties (8m CAD).
FTRP's Altman Z-Score is very low and is equal to 0.37.
Fundamental Analysis
Field Trip Health Ltd
Balance Sheet Decomposition
Field Trip Health Ltd
| Current Assets | 69.2m |
| Cash & Short-Term Investments | 63.7m |
| Receivables | 1.2m |
| Other Current Assets | 4.2m |
| Non-Current Assets | 33m |
| PP&E | 31.7m |
| Intangibles | 483.4k |
| Other Non-Current Assets | 728.2k |
| Current Liabilities | 8.4m |
| Accounts Payable | 5.8m |
| Other Current Liabilities | 2.6m |
| Non-Current Liabilities | 26.7m |
| Long-Term Debt | 26.7m |
Earnings Waterfall
Field Trip Health Ltd
|
Revenue
|
4.9m
CAD
|
|
Cost of Revenue
|
-9.2m
CAD
|
|
Gross Profit
|
-4.3m
CAD
|
|
Operating Expenses
|
-48.8m
CAD
|
|
Operating Income
|
-53m
CAD
|
|
Other Expenses
|
-1.6m
CAD
|
|
Net Income
|
-54.7m
CAD
|
Free Cash Flow Analysis
Field Trip Health Ltd
What is Free Cash Flow?
FTRP Profitability Score
Profitability Due Diligence
Field Trip Health Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
Score
Field Trip Health Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
FTRP Solvency Score
Solvency Due Diligence
Field Trip Health Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Field Trip Health Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FTRP Price Targets Summary
Field Trip Health Ltd
According to Wall Street analysts, the average 1-year price target for
FTRP
is 12.25 CAD
.
Shareholder Return
FTRP Price
Field Trip Health Ltd
| Average Annual Return | 47 808.34% |
| Standard Deviation of Annual Returns | 67 658.33% |
| Max Drawdown | -95% |
| Market Capitalization | 61.3m CAD |
| Shares Outstanding | 21 128 688 |
| Percentage of Shares Shorted | 0.34% |
Company Profile
Field Trip Health Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptors. Its Field Trip Health division operates clinics across North America and Europe providing Ketamine-assisted psychotherapy (KAT) under various programs. Through its Field Trip Digital, it builds the digital and technological tools to support psychedelic experiences and consciousness expansion. The firm provides Trip and Portal applications. Its Trip is an iOS and Android application for consciousness expansion. Its Portal is a digital health platform for clients participating in psychedelic therapies at Field Trip Health centers.
You don't have any saved screeners yet
